Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

bioMerieux recalls VIDAS chlamydia assay batches

This article was originally published in Clinica

Executive Summary

bioMerieux has recalled in the UK two batches of its VIDAS chlamydia CHL assay, following the discovery of stability problems with a raw material, which is "causing an accelerated degradation of performance". As a result of investigations carried out thus far, the company is urging users to re-test only those patients who were tested since July 24 2003 and for whom the result was negative with a value of 20 or greater.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel